Oral administration of RU 486 and 9-methylene PGE2 for termination of early pregnancy
- 1 May 1990
- journal article
- research article
- Published by Elsevier in Contraception
- Vol. 41 (5) , 461-473
- https://doi.org/10.1016/0010-7824(90)90056-2
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- The effect of the antiprogestin RU 486 on uterine contractility and sensitivity to prostaglandin and oxytocinBJOG: An International Journal of Obstetrics and Gynaecology, 1988
- INDUCTION OF THERAPEUTIC ABORTION IN EARLY PREGNANCY WITH MIFEPRISTONE IN COMBINATION WITH PROSTAGLANDIN PESSARYThe Lancet, 1987
- Menstrual regulation by intramuscular injections of 16‐phenoxy‐tetranor PGE2 methyl sulfonylamide or vacuum aspiration. A randomized multicentre studyBJOG: An International Journal of Obstetrics and Gynaecology, 1987
- Termination of early gestation with the anti-progestin steroid RU 486: Medium versus low doseContraception, 1987
- Uses of RU 486 for contragestion: An updateContraception, 1987
- Termination of Early Pregnancy by the Progesterone Antagonist RU 486 (Mifepristone)New England Journal of Medicine, 1986
- Therapeutic abortion in early pregnancy with antiprogestogen RU486 alone or in combination with prostaglandin analogue (Gemeprost)Contraception, 1986
- Progesterone receptor blockageContraception, 1985
- Termination of Early Pregnancy: Future developmentActa Obstetricia et Gynecologica Scandinavica, 1983
- Termination of early pregnancy (menstrual induction) with 16-phenoxy-ω-tetranor PGE2 methylsulfonylamideContraception, 1977